Publications Database

Goday P. (2008)

Whey watchers and wheat watchers: The case against gluten and casein in autism.

Nutrition in Clinical Practice

23 pp. 581-582

Gogou M. , Kolios G.

The effect of dietary supplements on clinical aspects of autism spectrum disorder: A systematic review of the literature.

Brain and Development

Read Abstract (New Window)

Goin-Kochel R. P. , Mackintosh V. H. , Myers B. J. (2009)

Parental reports on the efficacy of treatments and therapies for their children with autism spectrum disorders.

Research in Autism Spectrum Disorders

2(3), pp. 528-537

Read Abstract (New Window)

Goldacre B. (2009)

Bad science.

London: Harper Perennial

Goldfarb C. et al. (2016)

Hyperbaric oxygen therapy for the treatment of children and youth with autism spectrum disorders: An evidence-based systematic review.

September, 29 pp. 1-7.

Read Abstract (New Window)

Goldman R. H. , Woolf A. (2012)

Chelation therapy: guidance for the general public.

Boston, MA: New England Pediatric Environmental Health Specialty Unit

Read Full (New Window)

Gona J. K. et al. (2015)

Parents' and professionals' perceptions on causes and treatment options for autism spectrum disorders (ASD) in a multicultural context on the Kenyan coast.

PLoS ONE

10(8), e0132729.

Read Abstract (New Window) Read Full (New Window)

Gordon I. et al. (2013)

Oxytocin enhances brain function in children with autism.

Proceedings of the National Academy of Science U S A

110(52), pp. 20953-20958.

Read Abstract (New Window) Read Full (New Window)

Granpeesheh D. et al. (2010)

Randomized trial of hyperbaric oxygen therapy for children with autism.

Research in Autism Spectrum Disorders

4(2), pp. 268-275

Read Abstract (New Window)

Green V. A. et al. (2006)

Internet survey of treatments used by parents of children with autism.

Research in Developmental Disabilities

27(1), pp. 70-84

Read Abstract (New Window)

Gresham F. M. , Beebe-Frankenberger M. E. , MacMillan D. L. (1999)

A selective review of treatments for children with autism: Description and methodological considerations.

School Psychology Review

28(4), pp. 559-575

Read Full (New Window)

Gringras P. et al. (2012)

Melatonin for sleep problems in children with neurodevelopmental disorders: randomised double masked placebo controlled trial.

British Medical Journal

345 e6664

Read Full (New Window)

Gringras P. (2000)

Practical paediatric psychopharmacological prescribing in autism: the potential and the pitfalls.

Autism

4(3), pp. 229-247

Read Abstract (New Window)

Mercury Dextoxification Consensus Group (2005)

Mercury Detoxification Consensus Group Position Paper.

San Diego, CA: Autism Research Institute

Guénolé F. , Baleyte J. (2011)

Melatonin for sleep-disturbed children with autism spectrum disorders: can we really speak of a substitution treatment?

European Child and Adolescent Psychiatry

20(9), pp. 493-494.

Read Abstract (New Window)

Guastella A. J. et al. (2010)

Intranasal oxytocin improves emotion recognition for youth with autism spectrum disorders.

Biological Psychiatry

67(7), pp. 692-694

Read Abstract (New Window)

Guastella A. J. et al. (2015)

The effects of a course of intranasal oxytocin on social behaviors in youth diagnosed with autism spectrum disorders: a randomized controlled trial.

Journal of Child Psychology and Psychiatry

April, 56(4), pp. 444-452.

Read Abstract (New Window)

Gupta S. (2000)

Immunological treatments for autism.

Journal of Autism and Developmental Disorders

30(5), pp. 475-479

Read Abstract (New Window)

Gupta S. (1999)

Treatment of children with autism with intravenous immunoglobulin.

Journal of Child Neurology

14(3), pp. 203-205

Hadland S. E. , Knight J. R. , Harris S. K. (2015)

Medical marijuana: Review of the science and implications for developmental-behavioral pediatric practice.

Journal of Developmental and Behavioral Pediatrics

February, 36(2), pp. 115-123.

Read Abstract (New Window)